Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

High fluence low-power laser irradiation induces mitochondrial permeability transition mediated by reactive oxygen species

Furthermore, there existed a secondary signaling pathway through Bax activation. The observed link between MPT and triggering ROS could be a fundamental phenomenon in HF-LPLI-induced cell apoptosis.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied human lung adenocarcinoma cells (ASTC-a-1) exposed to high fluence low-power laser light at 633 nm and 120 J/cm(2). They report that cell death involved mitochondrial permeability transition driven by reactive oxygen species, with a secondary Bax-activation pathway. These are laboratory cell findings, so the results may not apply to living patients.

Who or what was studied
Human lung adenocarcinoma cells (ASTC-a-1) in laboratory culture
Wavelengths
633 nm
Limits stated in the abstract
The study was performed on cultured cancer cells in the laboratory, so its findings may not translate to humans or in vivo tissue.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
633 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Reactive oxygen species, Laser, Fluence, Mitochondria. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies